| Revenue growth | 23% growth in FY26, targeting ₹300cr in FY27. |
|---|---|
| Margins | PAT margin improved from 6% to 8.5%; targeting 11-12%. |
| Demand visibility | Strong data-led demand from existing D2C customer base. |
| Management confidence | High; confident in scaling to 1000 beds eventually. |
Growth
FY26 Revenue grew 23% to ₹200cr+; EBITDA rose 73%, PAT up 74% to ₹17cr.
Outlook
Revenue targets of ₹300cr (FY27) and ₹500cr (FY28). Scaling to 300 hospital beds by end of FY27.
Risks
High receivable days in hospital segment (30-60 days); pending RBI approval for US subsidiary equity subscription.
Earnings Call filed with NSE, NSE: SATKARTAR. Summary written with AI assistance from the document.
Sat Kartar Life Ltd: key numbers
- Share price
- ₹187.70
- Market cap
- ₹296.5 Cr
- Revenue (annual)
- ₹200.7 Cr
- Net profit (annual)
- ₹17.10 Cr
- P/E (TTM)
- 17.3×Sector 50.4×
- Promoter holding
- 63.62%
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sat Kartar Life Ltd
All →Sat Kartar Life Capacity Expansion: ₹0.7 Cr Investment
Sat Kartar Life signed an LOI for a 20-bed hospital-cum-therapy centre in Dehradun at ₹0.70 Crore. The facility is expected to be operational by December 2026.
- Value
- ₹0.70 Cr
- Execution
- by 15 December 2026
- hospital bed capacity
- 20 beds
Sat Kartar Life Earnings Call: Key Takeaways
Sat Kartar Life transitioned from a product-focused entity to a healthcare ecosystem, delivering record growth in FY26. Management is aggressively targeting 150% revenue growth by FY28 through massive hospital bed expansion and US market entry.
Sat Kartar Life H2 FY26 Results: Net Profit ₹9.8 Cr, Up 63.3% YoY
Sat Kartar Life Ltd reported revenue from operations of ₹110.6 Cr (+27.0% YoY) and net profit of ₹9.8 Cr (+63.3% YoY) for H2 FY26.
- Key figure
- Net profit ₹9.8 Cr · +63.3% YoY